ArticleCancer medicine2019

Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with Azacitidine.

Kamel Laribi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.